{"id":35276,"date":"2015-04-29T07:19:51","date_gmt":"2015-04-29T11:19:51","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=35276"},"modified":"2015-04-29T07:19:51","modified_gmt":"2015-04-29T11:19:51","slug":"drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276","title":{"rendered":"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16"},"content":{"rendered":"<p style=\"text-align: justify;\">A top-notch US-based drug-maker <strong>Pfizer Inc. (NYSE:PFE)<\/strong> has cut on its yearly revenues and next-yearly profit forecast. The company has put all its blame on a stronger dollar and higher exchange ratio.<\/p>\n<p style=\"text-align: justify;\"><strong>A Quarterly Review<\/strong><\/p>\n<p style=\"text-align: justify;\">In Q12015, the company notched up substantial profits, better than is potentially expected and anticipated. There has been a widespread demand for cancer drugs and vaccines manufactured and patented by PFE. In the last year, the pharmaceutical company got 60% revenue from pan-globe sales, primarily outside the US. Hence, on the premises of stronger extents of dollar value, the company has cut down its forecast from $44.5-$46.5 billion to a limit of $44-$46 billion.<\/p>\n<p style=\"text-align: justify;\"><strong>Numbers\u2019 Games<\/strong><\/p>\n<p style=\"text-align: justify;\">Though the numbers are a bit low than the previously expected forecast, yet the fact is when is such a negative vibe lingering among the PFE authorities. The think tank chose to reduce its entire yearly revenue, though by a meek margin.<\/p>\n<p style=\"text-align: justify;\">Pfizer Inc. (NYSE:PFE) has joined myriad of companies that have cut their forecast earlier in the month. The US dollar has lately gained 9% against a plethora of foreign currencies in the first quarter, after soaring 13% in FY2014. In the quarter that came to a close lately, the company has garnered net profits surpassing $2.38 billion, at a valuation of approximately 38 cents for each share. In a YoY basis, the company had garnered better gains in the last quarter, in comparison to the same profile, even a year back. In 2014, the company garnered net profits of $2.33 billion, valued at 36 cents each year.<\/p>\n<p style=\"text-align: justify;\">Beating the estimates by a number of analysts, Pfizer earned 51 cents for each share, in comparison to the net estimate ranging to 49 cents by<strong> Thomson Reuters Corporation (USA) (NYSE:TRI)<\/strong>. Despite stock indices falling, the company has fared the charts with profitability.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A top-notch US-based drug-maker Pfizer Inc. (NYSE:PFE) has cut on its yearly revenues and next-yearly profit forecast. The company has put all its blame on [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":5121,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[993,8526,2745,8525],"stock_ticker":[],"class_list":["post-35276","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nysepfe","tag-nysetri","tag-pfizer-inc-nysepfe","tag-thomson-reuters-corporation-usa-nysetri","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"A top-notch US-based drug-maker Pfizer Inc. (NYSE:PFE) has cut on its yearly revenues and next-yearly profit forecast. The company has put all its blame on [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-29T11:19:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16\",\"datePublished\":\"2015-04-29T11:19:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\"},\"wordCount\":307,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg\",\"keywords\":[\"NYSE:PFE\",\"NYSE:TRI\",\"Pfizer Inc (NYSE:PFE)\",\"Thomson Reuters Corporation (USA) (NYSE:TRI)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\",\"name\":\"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg\",\"datePublished\":\"2015-04-29T11:19:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg\",\"width\":400,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276","og_locale":"en_US","og_type":"article","og_title":"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16 - Wall Street PR","og_description":"A top-notch US-based drug-maker Pfizer Inc. (NYSE:PFE) has cut on its yearly revenues and next-yearly profit forecast. The company has put all its blame on [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-04-29T11:19:51+00:00","og_image":[{"width":400,"height":300,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16","datePublished":"2015-04-29T11:19:51+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276"},"wordCount":307,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg","keywords":["NYSE:PFE","NYSE:TRI","Pfizer Inc (NYSE:PFE)","Thomson Reuters Corporation (USA) (NYSE:TRI)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276","url":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276","name":"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg","datePublished":"2015-04-29T11:19:51+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/12\/Pfizer1.jpg","width":400,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/drug-maker-pfizer-inc-nysepfe-presents-poorer-yearly-forecast-for-2015-16-35276#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Drug-Maker Pfizer Inc. (NYSE:PFE) Presents Poorer Yearly Forecast For 2015-16"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/35276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=35276"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/35276\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/5121"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=35276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=35276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=35276"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=35276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}